Access
To read this story in full you will need to login or make a payment (see right).
Article
Nature 455, 627-632 (2 October 2008) | doi:10.1038/nature07314; Received 26 June 2008; Accepted 6 August 2008; Published online 27 August 2008
Open Innovation Challenges
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
nature jobs
Senior Executive- Finance Corporate Office
- Rhydburg Pharmaceuticals
- Selaqui-Dehradun India
Full-Professor of Heart and Thoracic Surgery (W3) (f / m)
- Friedrich-Schiller-University Jena
- Jena Germany
In vivo reprogramming of adult pancreatic exocrine cells to
-cells
Qiao Zhou1, Juliana Brown2, Andrew Kanarek1, Jayaraj Rajagopal1 & Douglas A. Melton1
- Department of Stem Cell and Regenerative Biology, Howard Hughes Medical Institute, Harvard Stem Cell Institute, Harvard University, 7 Divinity Avenue, Cambridge, Massachusetts 02138, USA
- Department of Pathology, Children's Hospital, Boston, Harvard Medical School, Harvard Stem Cell Institute, 300 Longwood Avenue, Boston, Massachusetts 02115-5724, USA
Correspondence to: Douglas A. Melton1 Correspondence and requests for materials should be addressed to D.A.M. (Email: dmelton@harvard.edu).
Abstract
One goal of regenerative medicine is to instructively convert adult cells into other cell types for tissue repair and regeneration. Although isolated examples of adult cell reprogramming are known, there is no general understanding of how to turn one cell type into another in a controlled manner. Here, using a strategy of re-expressing key developmental regulators in vivo, we identify a specific combination of three transcription factors (Ngn3 (also known as Neurog3) Pdx1 and Mafa) that reprograms differentiated pancreatic exocrine cells in adult mice into cells that closely resemble
-cells. The induced
-cells are indistinguishable from endogenous islet
-cells in size, shape and ultrastructure. They express genes essential for
-cell function and can ameliorate hyperglycaemia by remodelling local vasculature and secreting insulin. This study provides an example of cellular reprogramming using defined factors in an adult organ and suggests a general paradigm for directing cell reprogramming without reversion to a pluripotent stem cell state.
- Department of Stem Cell and Regenerative Biology, Howard Hughes Medical Institute, Harvard Stem Cell Institute, Harvard University, 7 Divinity Avenue, Cambridge, Massachusetts 02138, USA
- Department of Pathology, Children's Hospital, Boston, Harvard Medical School, Harvard Stem Cell Institute, 300 Longwood Avenue, Boston, Massachusetts 02115-5724, USA
Correspondence to: Douglas A. Melton1 Correspondence and requests for materials should be addressed to D.A.M. (Email: dmelton@harvard.edu).
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
New β-cells from old aciniNature Biotechnology News and Views (01 Oct 2008)
Regenerative medicine Short cut to cell replacementNature News and Views (02 Oct 2008)
See all 6 matches for News And ViewsRESEARCH
Cadmium dietary intake and biomarker data in French high seafood consumersJournal of Exposure Science and Environmental Epidemiology Article Response
NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in miceNature Medicine Article (01 May 2003)
See all 54 matches for Research
